20-45777146-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_080614.2(WFDC3):c.422C>A(p.Ala141Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000183 in 1,609,408 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_080614.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WFDC3 | NM_080614.2 | c.422C>A | p.Ala141Glu | missense_variant | 5/7 | ENST00000243938.9 | NP_542181.1 | |
WFDC3 | XM_011528553.3 | c.440C>A | p.Ala147Glu | missense_variant | 5/7 | XP_011526855.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WFDC3 | ENST00000243938.9 | c.422C>A | p.Ala141Glu | missense_variant | 5/7 | 1 | NM_080614.2 | ENSP00000243938.4 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152208Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000619 AC: 15AN: 242392Hom.: 0 AF XY: 0.0000532 AC XY: 7AN XY: 131628
GnomAD4 exome AF: 0.000191 AC: 278AN: 1457200Hom.: 0 Cov.: 31 AF XY: 0.000167 AC XY: 121AN XY: 725068
GnomAD4 genome AF: 0.000112 AC: 17AN: 152208Hom.: 0 Cov.: 31 AF XY: 0.0000807 AC XY: 6AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.422C>A (p.A141E) alteration is located in exon 5 (coding exon 4) of the WFDC3 gene. This alteration results from a C to A substitution at nucleotide position 422, causing the alanine (A) at amino acid position 141 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at